We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
CD43 antibody
Leukosialin
Galactoglycoprotein (GALGP)
Leukocyte sialoglycoprotein
Sialophorin
Gene name : SPN, CD43
Galactoglycoprotein (GALGP)
Leukocyte sialoglycoprotein
Sialophorin
Gene name : SPN, CD43
As low as
$323.40
In stock
Ref
00014728
One of the major glycoproteins of thymocytes and T lymphocytes. Plays a role in the physicochemical properties of the T-cell surface and in lectin binding. Presents carbohydrate ligands to selectins.
ID Covalab | pab0880-P |
---|---|
Product type | Primary antibodies |
Clonality | Polyclonal antibody |
Raised in | Rabbit |
Immunogen | Synthetic peptide derived from C terminal part of human CD43 protein |
Activity cross reaction | Reacts with human CD43 protein. |
Species | Hu |
Labelling | None |
Form | Purified (protein A) |
Preservative | None |
Storage instructions | Lyophilized powder stable for a minimum of 2 years at -20°C. Store reconstituted antibodies at +4°C. For extended periods store in aliquots at -20°C. Antibodies are guaranteed for 6 month from date of receipt. |
Target | CD43 |
Uniprot ID | P16150 |
Gene ID | 6693 |
Applications | ELISA, IHC, WB |
Working dilutions | Optimal dilutions should be determined by the end user. The following are guidelines only : WB 1:200 - 1:2000 IHC 1:100 - 1:1500 |
Publication | * Dwivedi V et al. Biochem Biophys Res Commun. 2018 Nov 17:506(1):60-65 (WB) * Fu Q et al. Intracellular patterns of sialophorin expression define a new molecular classification of breast cancer and represent new targets for therapy. Br J Cancer. 2013 Nov 26. * Fu Q et al. CD43 in the nucleus and cytoplasm of lung cancer is a potential therapeutic target. Int J Cancer. 2013 Apr 15:132(8):1761-70. |
Write Your Own Review